Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies. | Haematologica;94(11): 1625-7, 2009 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.

Meloni, Antonella; Favilli, Brunella; Positano, Vincenzo; Cianciulli, Paolo; Filosa, Aldo; Quarta, Antonella; D'Ascola, Domenico; Restaino, Gennaro; Lombardi, Massimo; Pepe, Alessia.

Haematologica ; 94(11): 1625-7, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19713229

Subject(s)

Gadolinium/toxicity; Hemoglobinopathies/complications; Adolescent; Adult; Child; Contrast Media/toxicity; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium/administration & dosage; Humans; Kidney Diseases; Male; Young Adult

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gadolinium / Hemoglobinopathies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Haematologica Year: 2009 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gadolinium / Hemoglobinopathies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Haematologica Year: 2009 Type: Article